Literature DB >> 8971097

Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion.

D Massillon1, N Barzilai, M Hawkins, D Prus-Wertheimer, L Rossetti.   

Abstract

The distal enzymatic step in the process of glucose output is catalyzed by the glucose-6-phosphatase (Glc-6-Pase) complex. The recently cloned catalytic unit of this complex has been shown to be regulated by insulin, dexamethasone, cAMP, and glucose. Using a combination of intralipid and/or nicotinic acid infusions and a pancreatic clamp technique, we maintained plasma free fatty acids (FFAs) at three different levels (0.26 +/- 0.07, 0.56 +/- 0.09, and 1.59 +/- 0.12 mmol/l) in the presence of well-controlled hormonal and metabolic conditions. An increase in the plasma FFA concentration within the physiological range caused a rapid, greater than threefold increase in the mRNA and protein levels of the catalytic subunit of Glc-6-Pase in the liver. These data indicate that the in vivo gene expression of Glc-6-Pase in the liver is regulated by circulating lipids independent of insulin and thus that prolonged hyperlipidemia may contribute to the increased production of glucose via increased expression of this protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8971097     DOI: 10.2337/diab.46.1.153

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

1.  Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.

Authors:  P Iozzo; R Lautamaki; F Geisler; K A Virtanen; V Oikonen; M Haaparanta; H Yki-Jarvinen; E Ferrannini; J Knuuti; P Nuutila
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

Review 2.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA).

Authors:  Arianna Maiorana; Chiara Del Bianco; Stefano Cianfarani
Journal:  Rev Diabet Stud       Date:  2007-11-10

4.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

5.  Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.

Authors:  K A Bennett; M Hammill; S Currie
Journal:  J Comp Physiol B       Date:  2013-06-07       Impact factor: 2.200

6.  Fatty acid-induced beta cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content.

Authors:  Y Q Liu; K Tornheim; J L Leahy
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 7.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

8.  Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.

Authors:  Seung-Soon Im; Mi-Young Kim; Sool-Ki Kwon; Tae-Hyun Kim; Jin-Sik Bae; Hail Kim; Kyung-Sup Kim; Goo-Taeg Oh; Yong-Ho Ahn
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

9.  Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription.

Authors:  R S Streeper; E M Eaton; D H Ebert; S C Chapman; C A Svitek; R M O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 10.  Fat-induced liver insulin resistance.

Authors:  Pankaj Shah; Ananda Basu; Robert Rizza
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.